Expertise in
13
conditions

Kate Riney

501 Stanley St, 
South Brisbane, QLD, AU 
Expertise in
13
conditions
501 Stanley St, 
South Brisbane, QLD, AU 

Overview

Kate Riney practices practicing medicine in South Brisbane, Australia.

Ms. Riney is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Tuberous Sclerosis Complex, Tuberous Sclerosis, Lennox-Gastaut Syndrome (LGS), and Cortical Dysplasia.

She is actively involved in clinical research, co-authoring 55 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

501 Stanley St, South Brisbane, QLD 4101, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

CORE-VNS: Comprehensive Outcomes Registry in Subjects With Epilepsy Treated With Vagus Nerve Stimulation Therapy
CORE-VNS: Comprehensive Outcomes Registry in Subjects With Epilepsy Treated With Vagus Nerve Stimulation Therapy
Enrollment Status: Completed
Publish Date: November 22, 2024
Intervention Type: Device
A Phase 2/3, Multi-Center, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Dose-Response Comparison of the Efficacy and Safety of a Topical Rapamycin Cream for the Treatment of Facial Angiofibromas (FA) Associated With Tuberous Sclerosis Complex (TSC) in Patients 6 Years of Age and Over
A Phase 2/3, Multi-Center, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Dose-Response Comparison of the Efficacy and Safety of a Topical Rapamycin Cream for the Treatment of Facial Angiofibromas (FA) Associated With Tuberous Sclerosis Complex (TSC) in Patients 6 Years of Age and Over
Enrollment Status: Completed
Publish Date: September 08, 2023
Intervention Type: Drug
Study Drug: Rapamycin
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

55 Total Publications

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.
Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.
Journal: Epilepsia open
Published: April 01, 2026

Frequently Asked Questions about Kate Riney

Is Kate Riney a top-rated expert for Tuberous Sclerosis Complex?

MediFind is an objective health platform that identifies experts based on real-world data. Kate Riney is classified as an Distinguished expert for Tuberous Sclerosis Complex, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kate Riney participate in research or clinical trials?

Yes. Kate Riney has published 55 articles and abstracts on conditions like Tuberous Sclerosis Complex. You can view a list of Kate Riney's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Riney's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile